We have located links that may give you full text access.
Trends in transfusion rates after the FOCUS trial.
Journal of Comparative Effectiveness Research 2018 Februrary
AIM: We estimate the impact of the FOCUS trial, which concluded that hip surgery patients with hemoglobin values above 8 g/dl do not benefit from routine transfusions, on transfusion rates.
METHODS: We evaluated trends in transfusion rates using inpatient discharge data from four states.
RESULTS: The transfusion rate was 5.2 percentage points lower in the fourth quarter of 2013 than it would have been had pre-FOCUS trends continued. Transfusion rates declined more in hospitals with a low end-of-life treatment intensity index, a general measure of treatment intensity.
CONCLUSION: The FOCUS trial affected practice, but there are additional opportunities to reduce the use of transfusions.
METHODS: We evaluated trends in transfusion rates using inpatient discharge data from four states.
RESULTS: The transfusion rate was 5.2 percentage points lower in the fourth quarter of 2013 than it would have been had pre-FOCUS trends continued. Transfusion rates declined more in hospitals with a low end-of-life treatment intensity index, a general measure of treatment intensity.
CONCLUSION: The FOCUS trial affected practice, but there are additional opportunities to reduce the use of transfusions.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app